[Diagnosis and treatment of faciocervical lymphatic malformations in infant]

Jing Ma1, Zhiyong Mao1, Fan Lou1

  • 1Department of Otorhinolaryngology, Kunming Children's Hospital (Children's Hospital Affiliated Kunming Medical University), Kunming 650228, China.

Insights

Surgical treatment effectively addresses infant head and neck lymphatic malformations (LMs). For large or microcystic LMs, pingyangmycin injection followed by secondary surgery can prevent complications.

Area of Science:

  • Pediatric Surgery
  • Vascular Anomalies
  • Head and Neck Surgery

Background:

  • Lymphatic malformations (LMs) are congenital vascular anomalies.
  • Head and neck LMs present unique challenges in infant treatment.
  • Effective management strategies are crucial to minimize morbidity.

Purpose of the Study:

  • To evaluate the treatment outcomes of head and neck lymphatic malformations in infants.
  • To compare the efficacy of different treatment modalities.
  • To identify optimal management strategies for complex cases.

Main Methods:

  • Retrospective analysis of 46 infant head and neck LMs (2009-2013).
  • Patients aged 9 months to 4 years.
  • Treatments included Phase I/II surgical resection and pingyangmycin injection.

Main Results:

  • Surgical resection was performed in 28 cases.
  • Pingyangmycin injection was used in 18 cases.
  • Two complications occurred: facial nerve branch paralysis and accessory nerve injury, both improved with treatment.

Conclusions:

  • Surgical intervention is an effective treatment for infant head and neck LMs.
  • Pingyangmycin injection is a viable option for large or microcystic LMs.
  • A staged approach, including secondary surgery, may be necessary for extensive LMs to avoid complications.
Abstract

Related Concept Videos